Sljedeći

Auto Play

Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma

4 Pogledi • 07/18/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play